Bethesda, MDNCT05531786Now EnrollingIRB Ready

Graft-Versus-Host Disease Clinical Trial in Bethesda, MD

Access cutting-edge graft-versus-host disease treatment through this clinical trial at a research site in Bethesda. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this Bethesda location

Preparing your pre-screening questions...

Expert Care in Bethesda

Access graft-versus-host disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related graft-versus-host disease treatment provided free

Apply for This Bethesda Location

Check if you qualify for this graft-versus-host disease clinical trial in Bethesda, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bethesda

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bethesda site if eligible
  4. 4Begin participation

About This Graft-Versus-Host Disease Study in Bethesda

Background: Chronic graft-versus-host disease (cGVHD) is an immune system disorder that can occur in people who have had a stem cell transplant. cGVHD can affect multiple organs and increase risk of disability and death. New treatments are needed to treat cGVHD after stem cell transplant. Objective: To test a drug (pacritinib) in people with moderate or severe cGVHD that has not responded to previous treatment. Eligibility: People aged 18 years and older with moderate or severe cGVHD that h

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

Moderate or severe cGVHD (after allogeneic hematopoietic stem cell transplantation) diagnosed and staged per NIH criteria 2. cGVHD that did not respond to \>=2 lines of prior systemic therapy. Disease that has failed prior systemic therapy will be defined as follows: a) For prior corticosteroid-containing regimens, disease that: i) recurs after achievement of a CR, or ii) progresses after achievement of a PR, or iii) progresses after at least 1 week of prednisone equivalent of 1 mg/kg/day, or iv) is stable and persistent after at least 4 weeks of a prednisone equivalent of 0.5 mg/kg/day OR, b) For other systemic therapies, disease that: i) recurs after achievement of CR, or ii) progresses after achievement of a PR, or iii) is stable and persistent despite 4 weeks of therapeutic dosing of systemic therapy 3. Karnofsky performance score \>=60% 4. Age \>=18 years. 5. If participant is taking systemic therapy for cGVHD at

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bethesda?

Yes, this clinical trial (NCT05531786) has an active research site in Bethesda, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Graft-Versus-Host Disease Treatment Options in Bethesda, MD

If you're searching for graft-versus-host disease treatment options in Bethesda, MD, this clinical trial (NCT05531786) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bethesda research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all graft-versus-host disease clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Bethesda, MD

See all atrial fibrillation clinical trials recruiting in Bethesda — not just this study.

Browse Atrial Fibrillation Trials in Bethesda →

Browse More Trials by Condition

Atrial Fibrillation TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Bethesda?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bethesda, MD